Literature DB >> 25373810

Nonmotor Symptoms and Cognitive Decline in de novo Parkinson's Disease.

Kyum-Yil Kwon1, Sung Hoon Kang1, Minjik Kim1, Hye Mi Lee1, Ji Wan Jang1, Ju Yeon Kim2, Seon-Min Lee1, Seong-Beom Koh1.   

Abstract

BACKGROUND: Cognitive impairments are common in Parkinson's disease (PD). Despite its clinical importance, the development of dementia is still difficult to predict. In this study, we investigated the possible associations between non-motor symptoms and the risk of developing dementia within a 2-year observation period in PD.
METHODS: A total of 80 patients with PD participated in this study. Nonmotor symptoms (the Nonmotor Symptoms Questionnaire), PD status (Unified Parkinson's Disease Rating Scale), depression (Geriatric d Depression Scale or Montgomery-Asberg Depression Scale), stereopsis and severity of nonmotor symptoms (Non-motor symptoms scale) were assessed. Global cognitive function (Mini-Mental State Examination) were evaluated at baseline and 2 years later.
RESULTS: Presence of depression, vivid dreaming, REM sleep behavior disorders, hyposmia, abnormal stereopsis, non-smoking and postural instability/ gait disturbance phenotype were associated with a significantly more rapid decline of Mini-Mental State Examination. Logistic regression analyses demonstrated that depression (odds ratio=13.895), abnormal stereopsis (odds ratio=10.729), vivid dreaming (odds ratio=4.16), REM sleep behavior disorders (odds ratio=5.353) and hyposmia (odds ratio=4.911) were significant independent predictors of dementia risk within 2 years. Postural instability/ gait disturbance phenotype and age >62 years were also independent predictors of dementia risk (odd ratio=38.333, odds ratio=10.625).
CONCLUSIONS: We suggest that depression, vivid dreaming, REM sleep behavior disorders, hyposmia and abnormal stereopsis are closely associated with cognitive decline, and that presence of these nonmotor symptoms predict the subsequent development of Parkinson's disease dementia.

Entities:  

Mesh:

Year:  2014        PMID: 25373810     DOI: 10.1017/cjn.2014.3

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  11 in total

1.  Cognitive Impairment and Mortality in a Population-Based Parkinson's Disease Cohort.

Authors:  Adrienne M Keener; Kimberly C Paul; Aline Folle; Jeff M Bronstein; Beate Ritz
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

2.  Dream Content Predicts Motor and Cognitive Decline in Parkinson's Disease.

Authors:  Abidemi I Otaiku
Journal:  Mov Disord Clin Pract       Date:  2021-08-09

Review 3.  Many Faces of Parkinson's Disease: Non-Motor Symptoms of Parkinson's Disease.

Authors:  Hye Mi Lee; Seong-Beom Koh
Journal:  J Mov Disord       Date:  2015-05-31

Review 4.  Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

Authors:  Jose A Santiago; Virginie Bottero; Judith A Potashkin
Journal:  Front Aging Neurosci       Date:  2017-12-04       Impact factor: 5.750

Review 5.  Apathy following Bilateral Deep Brain Stimulation of Subthalamic Nucleus in Parkinson's Disease: A Meta-Analysis.

Authors:  Ying Wang; Yongsheng Li; Xiaona Zhang; Anmu Xie
Journal:  Parkinsons Dis       Date:  2018-05-21

6.  Associations Between Olfactory Impairment and Cognitive Functions in Patients with Parkinson Disease.

Authors:  Nilüfer Büyükkoyuncu Pekel; Demet Yildiz; İbrahim Taymur; Ersin Budak; Suay Özmen; Çağla Çapkur; Meral Seferoğlu; Aygül Güneş; Deniz Siğirli
Journal:  Noro Psikiyatr Ars       Date:  2019-02-05       Impact factor: 1.339

Review 7.  The range and nature of non-motor symptoms in drug-naive Parkinson's disease patients: a state-of-the-art systematic review.

Authors:  Panagiotis Zis; Roberto Erro; Courtney C Walton; Anna Sauerbier; Kallol Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2015-07-09

8.  CSF Aβ1-42 level is associated with cognitive decline in early Parkinson's disease with rapid eye movement sleep behavior disorder.

Authors:  Maowen Ba; Guoping Yu; Min Kong; Hui Liang; Ling Yu
Journal:  Transl Neurodegener       Date:  2018-10-08       Impact factor: 8.014

9.  Risk of dementia after Parkinson's disease in Taiwan: a population-based retrospective cohort study using National Health Insurance claims.

Authors:  Chung-Yi Li; Susan C Hu; Chih-Ching Liu; Yu Sun; Pei-Chen Lee
Journal:  BMJ Open       Date:  2019-03-03       Impact factor: 2.692

Review 10.  Olfactory Dysfunction in Familial and Sporadic Parkinson's Disease.

Authors:  Bruce A Chase; Katerina Markopoulou
Journal:  Front Neurol       Date:  2020-05-29       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.